** Analysts at Bell Potter initiate research on Australia's Sigma Healthcare SIG.AX at A$2 PT and "sell" recommendation on stock

** PT is at an over 30% discount compared to SIG's last close of A$2.86

** Brokerage says current market capitalisation is not supported by expectations for earnings growth or dividend yield

** Sees 2H25 earnings to be weaker (relative to 1H25) as is the normal seasonal trend

** Expects a convergence on consensus earnings for FY26 following FY25 reporting in August

** Three of eight analysts rate the stock "buy", four "hold" and one "sell"; their median PT is A$2.95 – according to data compiled by LSEG

** Stock up 9.2% YTD

(Reporting by Rishav Chatterjee in Bengaluru; Editing by Lincoln Feast.)

((Rishav.Chatterjee@thomsonreuters.com;))